In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

Avinger, Inc.. Trade Record

NASDAQ:AVGR Avinger, Inc. stock gains 18.44% Exit Sep 13, 2018 a Trade Record by priceseries

Trade Chart
Trade Chart AVGR Aug 23, 2018, priceSeries
About Avinger, Inc.

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and Europe. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, which are designed to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its first-generation chronic total occlusion (CTO)-crossing catheters, Wildcat, and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. The company sells and markets its products to interventional cardiologists, vascular surgeons, and interventional radiologists. Avinger, Inc. was founded in 2007 and is headquartered in Redwood City, California.

Trade Information
Trade Type
LONG
ReliabilityScore™
96.88
Entry Date
Aug 23, 2018
Entry Price
12.70
Sell Date
Sep 13, 2018
Sell Price
15.04
Net Gain
18.44%
Hold Time
14 Trading Days